Pliant Therapeutics, Inc. $PLRX Stock Position Raised by ADAR1 Capital Management LLCMarket Beat·1 day ago, 02:13 AMPLRX+0.95%JPM+1.78%
Coastal Financial (CCB) Could Be 52% Undervalued On Pliant US PartnershipSimplywall·Jul 14 at 12:08 PMCCB-43.52%PLRX+0.95%
Pliant Therapeutics director Flavia Borellini files initial beneficial ownership statementPUBT·Jul 13 at 03:33 PMPLRX+0.95%
Pliant Therapeutics appoints Flavia Borellini, Robert Iannone to boardPUBT·Jul 13 at 08:16 AMPLRX+0.95%
Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting | PLRX Stock NewsStockTitan·May 21 at 08:30 AMPLRX+0.95%
Atisama Therapeutics Advances RB042 into Multiple Ascending Dose cohorts of Phase 1 Trial and Appoints Bernard Coulie as Chair of the Board | PLRX Stock NewsStockTitan·May 15 at 01:25 AMPLRX+0.95%
Oppenheimer Sticks to Its Hold Rating for Pliant Therapeutics (PLRX)Tip Ranks·May 12 at 11:55 PMPLRX+0.95%PBE-3.00%
Pliant Therapeutics (PLRX) Expected to Announce Quarterly Earnings on MondayMarket Beat·May 6 at 09:18 AMPLRX+0.95%ARKG+4.69%
Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting | PLRX Stock NewsStockTitan·Apr 18 at 04:31 AMPLRX+0.95%
Pliant Therapeutics Launches New $50 Million ATM ProgramTip Ranks·Mar 30 at 05:54 PMBIB+1.48%PBE-3.00%
